Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In recent years, advances in genomic and proteomic technologies have provided new insights into the various mechanisms that maintain mitochondrial protein homeostasis
Even small mistakes can cause big problems
The PROactive 294 trial showed that pioglitazone, compared with a placebo, reduced the risk of composite outcomes (all-cause mortality, nonfatal MI and stroke) by 16% in diabetic patients with established ASCVD
Diindolylmethane and Its Halogenated Derivatives Induce Protective Autophagy in Human Prostate Cancer Cells via Induction of the Oncogenic Protein AEG-1 and Activation of AMP-Activated Protein Kinase (AMPK). Cellular Signalling, vol
US$ 24.21
US$ 27.55
US$ 25.37
.webp)
US$ 29.84
US$ 23.10
